Transcranial Doppler in migraine attacks before and after treatment with oral zolmitriptan or sumatriptan

Headache

Volumn 43, Issue 1, 2003, Pages 54-58

  Thomaides, Thomas ^b   Karagounakis, Demetrios ^a   Spantideas, Anastasios ^b   Katelanis, Stavros ^a  

^a 1st IKA Hospital   (Greece)

^b NONE

Author keywords

Migraine; Sumatriptan; Transcranial Doppler; Zolmitriptan

Indexed keywords

GLYCERYL TRINITRATE; SUMATRIPTAN; ZOLMITRIPTAN;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; MALE; MIDDLE CEREBRAL ARTERY; MIGRAINE; PRIORITY JOURNAL; ULTRASOUND;

ADULT; BLOOD FLOW VELOCITY; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MALE; MIGRAINE WITHOUT AURA; OXAZOLIDINONES; SEROTONIN AGONISTS; TRYPTAMINES; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 0347895055     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2003.03009.x     Document Type: Article

References (28)

1. Silvestrini M, Mateis M, Troisi E, Cupini L, Bernardi G. Cerebrovascular reactivity in migraine with and without aura. Headache. 1996;36:37-40.
2. Naterro G, Mengozzi G, Inconis T, Paradisi L. Nitric oxide, Endothelin 1 and Transcranial Doppler in migraine findings interictal conditions and during migraine attack. Headache. 1996;36:307-311.
3. Olesen J. The pathophysiology of migraine. In: Rose FC, ed. Handbook of Clinical Neurology, IV. Amsterdam: Elsevier;1986, pp. 59-83.
4. Meyer JS, Hata T, Imai A. Evidence supporting a vascular pathogenesis of migraine and cluster headache. In: Blaw JN, ed. Migraine Clinical Therapeutic Conceptual and Research aspects. London: Chapman and Hall;1987, pp. 265-302.
5. Diener HC, Haab J, Peters C, Ried S, Dichgans J, Pilgrim A. Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache. 1991;31:205-209.
6. Frieberg L, Olesen J, Iversen HK, Sperling B. Migraine pain associated with middle cerebral artery dilatation reversal by sumatriptan. Lancet. 1991;338:13-17.
7. De Benedittis G, Ferrari Da Passano C, Granata G, Lorenzetti A. CBF changes during headache-free periods and spontaneous/induced attacks in migraine with and without aura: a TCD and SPECT comparison study. J Neurosurg Sci. 1999;43:141-146.
8. Heckmann JG, Hilz MJ, Katalinic A, Marthol H, Muck-Weymann M, Neundorfer B. Myogenic cerebrovascular autoregulation in migraine measured by stress transcranial Doppler sonography. Cephalalgia. 1998;18:133-137.
9. Baezner H, Steinke W, Daffertshofer M, Hennerici M. Vasoneuronal coupling in migraineurs after subcutaneous Sumatriptan: a TCD study. J Neurol Sci. 1999;167:50-55.
10. Becher G, Griewing B. Examination technique. In: Bogdahn U, Becker G, Schlachetzki F, eds. Echoenhancers and Transcranial Color Duplex Sonography. Berlin: Blackwell Wissenschafts-Verlag;1998, pp. 229-231.
11. Headache Classification Committee of the International Headache Society classification and diagnostic criteria for headache disorders, cranial neuralgia and facial pain. Cephalalgia. 1988;(suppl 7):1-96.
12. Zanette EM, Agnoli A, Cerbo R, Chiarotti F, Roberti C, Buzzi G, Fleschi C. Transcranial doppler after nitroglycerin in migraine without aura. Headache. 1991;31:596-598.
13. Arnold BJ, Vol Reutern G-M. Transcranial Doppler sonography examination technique and normal reference values. Ultrasound Med Biol. 1986;12:115-123.
14. Griewing B, Becker G. Vascular Anatomy and Flow Velocities in Echoenhancers and Transcranial Color Duplex Sonography. Berlin: Blackwell Wissenschafts-Verlag; 1998, pp. 251-259.
15. Totaro R, De Matteis G, Marini C, Prencipe M. Cerebral blood flow in migraine with aura: a transcranial Doppler sonography study. Headache. 1992;32:446-451.
16. Tegeler CH, Davidai G, Gengo FM, Knappertz VA, Troost BT, Gabriel H, Davis RL. Middle cerebral artery velocity correlates with nitroglycerin induced headache onset. J Neuroimaging. 1996;6:81-86.
17. Martin G. Inhibition of the trigeminovascular system with 5 HTID agonist drugs: selectively targeting additional sites of action. Eur Neurol. 1996;36:13-18.
18. Iversen HK, Holms S, Friberg L. Intracranial haemodynamics during intravenous nitroglycerin infusion. Cephalalgia. 1989;(suppl 10)84-85.
19. Dahl A, Russell D, Nyberg, Hansen R, Rootwell K. Effect of nitroglycerin on cerebralstimulation measured by transcranial Doppler and SPECT. Stroke. 1989;20:1733-1736.
20. Thomsen L, Iversen H, Brinck A, Olesen J. Arterial supersensitivity to nitric oxide (nitroglycerin) in migraine sufferers. Cephalalgia. 1993;13:395-399.
21. Faraci FM, Brian JE. Nitric oxide and the cerebral circulation. Stroke. 1994;25:692-703.
22. Ignarro LJ, Buga GM, Wood KS, et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987;84:9265-9269.
23. Shekhar YC, Anand IS, Sarma R, Ferrari R, Wahl PL, Pool-Wilson PA. Effects of prolonged infusion of human α-calcitonin, gene-related peptide on hemodynamics, renal blood flow, and hormone levels in congestive heart failure. Am J Cardiol. 1991;67:732-736.
24. Parsons AA, Whalley ET. Characterization of the hydrotryptamine receptor which mediates contraction of the human isolated basilar artery. Cephalalgia. 1989;9:47-51.
25. Meloche J. Triptans and migraine: Which drug for which patient? Can J Diagnosis. 1999;16:67-77.
26. De Clerek F, Reneman RS. Platelet-derived serotonin and abnormal tissue perfusion. In: Vanhoutte RM, ed. Serotonin and the Cardiovascular System. New York: Raven Press;1985, pp. 155-164.
27. Iversen HK, Olesen J. Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. Cephalalgia. 1996;16:412-418.
28. Schmetterer L, Wolzt M, Krejcy K, Graselli U, Findl O, Eichler H-G, Singer EA. Cerebral and ocular hemodynamic effects of sumatriptan in the nitroglycerin headache model. Clin Pharmacol Ther. 1996;60:99-205.